Terms ending in 2040
Every in-force patent on Chdi Foundation, Inc.'s record whose computed term ends in 2040, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 12,083,108 | Compounds for Targeting Mutant Huntingtin Protein and Uses Thereof In force · High confidence | Chdi Foundation, Inc. | In force | High confidence | |
| US 11,389,438 | Compounds for Targeting Mutant Huntingtin Protein and Uses Thereof In force · High confidence | Chdi Foundation, Inc. | In force | High confidence | |
| US 11,421,007 | Zinc Finger Protein Compositions for Modulation of Huntingtin (HTT) In force · High confidence | Sangamo Therapeutics, Inc. | In force | High confidence | |
| US 11,173,156 | Solid Forms of a KYNURENINE-3-Monooxygenase Inhibitor In force · High confidence | Chdi Foundation, Inc. | In force | High confidence |
4 of 4 patents shown. Soonest term end first, then patent number.
3 of these are in force and held by Chdi Foundation, Inc..
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.